Amgen (AMGN) Equity Ratio (2009 - 2026)

Amgen's Equity Ratio history runs 18 years deep, the most recent figure standing at 0.1 for Q1 2026.

• In Q1 2026, Equity Ratio rose 43.04% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (up 43.04% YoY), while the FY2025 annual figure was 0.1, up 49.36% from the prior year.
• Equity Ratio was 0.1 for Q1 2026 at Amgen, up from 0.1 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.11 in Q3 2025 to a low of 0.02 in Q1 2022.
• Historically, Equity Ratio has averaged 0.07 across 5 years, with a median of 0.07 in 2024.
• The sharpest annual moves came in 2022 and 2023: Equity Ratio sank 89.63% in 2022, then surged 289.55% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.06 in 2022, then rose by 14.1% to 0.06 in 2023, then declined by 0.24% to 0.06 in 2024, then surged by 49.36% to 0.1 in 2025, then rose by 3.94% to 0.1 in 2026.
• The last three Equity Ratio figures came in at 0.1 (Q1 2026), 0.1 (Q4 2025), and 0.11 (Q3 2025), per Business Quant data.